Search clinical trials for: Incretin analogues

Total 2056 results

Phoenix VA Health Care System
Novo Nordisk A/S

Unknown

The Effect of Liraglutide on Dietary Lipid Induced Insulin Resistance in Humans

Insulin Resistance

United States
Fudan University

Unknown

Clinical Study on the Improvement of Diabetic Neuropathic Pain by Liraglutide

Diabetic Neuropathic Pain
University of Miami

Completed

Effect of Liraglutide on Epicardial Fat in Subjects With Type 2 Diabetes

Obesity | Overweight | Type 2 Diabetes

United States
University of Chicago

Completed

Impact of Exenatide on Sleep in Type 2 Diabetes

Type 2 Diabetes | Sleep Disordered Breathing

United States
Novo Nordisk A/S

Completed

Investigating Safety, Tolerability, PK and PD for Multiple Doses of NNC9204-0530 in Combination With Liraglutide in Male and Female Subjects Being Overweight or With Obesity

Obesity | Metabolism and Nutrition Disorder

United States
Novo Nordisk A/S

Completed

Metabolism and Excretion of Liraglutide in Healthy Male Volunteers

Healthy | Diabetes

Netherlands
GlaxoSmithKline

Completed

Safety and Efficacy of Albiglutide in Type 2 Diabetes

Diabetes Mellitus, Type 2

United States, United Kingdom, Korea, Republic of, Peru, South Africa, India
Children's Hospital Los Angeles

Completed

Effects of Exenatide on Overweight Adolescents With Prader-Willi Syndrome

Prader-Willi Syndrome

United States
Chinese PLA General Hospital

Unknown

Effects of Glucagon Like Peptide-1 on Haemodynamic Parameters

Heart Failure

China
AstraZeneca
Eli Lilly and Company

Completed

Safety of Exenatide Once Weekly in Patients With Type 2 Diabetes Mellitus Treated With Thiazolidinedione Alone or Thiazolidinedione in Combination With Metformin

Type 2 Diabetes

United States, Romania, Canada, Mexico, South Africa
University of Rome Tor Vergata
Merck Sharp & Dohme LLC

Completed

Glucagon-like Peptide 1 (GLP-1) and Endothelial Dysfunction in Metabolic Syndrome

Metabolic Syndrome

Italy
Huashan Hospital

Unknown

Effects of Exenatide on Obesity and/or Diabetes Mellitus Due to Hypothalamic Damage

Diabetes Mellitus | Hypothalamic Obesity

China
University of Minnesota

Completed

GLP-1 Therapy for Weight Loss and Improved Glucose Tolerance in Obese Children

Obesity, Morbid

United States
Medical University of Vienna

Completed

The Influence of Liraglutide on the Reward Properties of Food: an fMRI Study on Healthy Volunteers

Healthy Human Male Subjects

Austria
Ruhr University of Bochum

Completed

Effects of Exenatide (Byetta®) on Liver Function in Patients With Nonalcoholic Steatohepatitis (NASH)

Nonalcoholic Fatty Liver Disease

Germany
Assiut University

Completed

Insulin in Treatment of Diabetes Mellitus With Pregnancy

Diabetes
Amgen

Completed

Multiple Ascending Dose Study of AMG 598 in Adults With Obesity

Obesity

United States
Eli Lilly and Company

Completed

A Study of Tirzepatide (LY3298176) Versus Placebo in Participants With Type 2 Diabetes Inadequately Controlled on Insulin Glargine With or Without Metformin (SURPASS-5)

Type 2 Diabetes

United States, Puerto Rico, Spain, Japan, Germany, Czechia, Poland, Slovakia
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Completed

Human Bioequivalence Test of Liraglutide Injection

Type 2 Diabetes

China
Novo Nordisk A/S

Completed

Efficacy and Safety of Liraglutide in Combination With Metformin Compared to Metformin Alone, in Children and Adolescents With Type 2 Diabetes (Ellipse™)

Diabetes Mellitus, Type 2 | Diabetes

United States, Croatia, India, Russian Federation, Spain, United Kingdom, Austria, Belgium, Mexico, Sweden, Israel, Taiwan, Hungary, Malaysia, Serbia, Turkey, Denmark, Greece, Thailand, North Macedonia, Norway, Portugal, Germany, Romania and more
University Hospitals Coventry and Warwickshire...
University of Warwick; University of Birmingham; Kingston University

Unknown

3mg Liraglutide for Overweight or Obesity

Obesity | Overweight | Infertility, Female

United Kingdom
Novo Nordisk A/S

Withdrawn

Non-interventional, Post Marketing Surveillance Study of Xultophy™ (Insulin Degludec/Liraglutide) to Evaluate Long Term Safety and Efficacy in Patients With Type 2 Diabetes Mellitus in Routine Clinical Practice in India

Diabetes Mellitus, Type 2 | Diabetes
Novo Nordisk A/S

Completed

A Clinical Trial Comparing Efficacy and Safety of Insulin Degludec/Liraglutide (IDegLira) in Subjects With Type 2 Diabetes Mellitus Using Two Different Titration Algorithms (DUAL™ VI)

Diabetes Mellitus, Type 2 | Diabetes

United States, Slovakia, Canada, Austria, Hungary, Serbia, Russian Federation, Bulgaria, Czechia
Novo Nordisk A/S

Completed

Effect of Liraglutide on Pulsatile Insulin Secretion in Subjects With Type 2 Diabetes

Diabetes Mellitus, Type 2 | Diabetes

Denmark
Novo Nordisk A/S

Completed

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Liraglutide in Healthy Japanese Volunteers

Diabetes Mellitus, Type 2 | Diabetes

Japan
AstraZeneca
Eli Lilly and Company

Terminated

Effect of Exenatide on Abdominal Fat Distribution in Patients With Type 2 Diabetes Pretreated With Metformin

Diabetes Mellitus

United States, Canada
AstraZeneca
Eli Lilly and Company

Completed

Comparison of Exenatide Taken Before Lunch and Dinner With Before Breakfast and Dinner in Patients With Type 2 Diabetes

Type 2 Diabetes

Brazil, Mexico
Eli Lilly and Company

Completed

A Study Comparing the Effect of Dulaglutide With Liraglutide in Type 2 Diabetes (AWARD-6)

Type 2 Diabetes

United States, Germany, Puerto Rico, Hungary, Spain, Poland, Mexico, Romania, Slovakia, Czech Republic
University of Aarhus
Novo Nordisk A/S; University of Copenhagen

Completed

Effects of Liraglutide on Kidney Function in Type 2 Diabetic Patients

Type 2 Diabetes Mellitus

Denmark
University Health Network, Toronto
Eli Lilly and Company

Completed

Exenatide (Byetta ®) Regulation of Intestinal and Hepatic Lipoprotein Particle Production in Humans

Hyperlipidemia

Canada
Noah Hahn, M.D.
Bristol-Myers Squibb

Terminated

Neoadjuvant Dasatinib Plus LHRH Analogue Therapy in High-Risk Localized Prostate Cancer

Prostate Cancer

United States
Merck KGaA, Darmstadt, Germany

Completed

Phase 3 Trial to Evaluate the Efficacy and Safety of COL-1620 Vaginal Progesterone Gel

Embryo Transfer | Luteal Hormone Supplementation in In-vitro Fertilization

Japan
Novo Nordisk A/S

Not yet recruiting

A Research Study in Italy to Understand How the Dose Check App Used With Xultophy® Works in the Treatment of People Living With Type 2 Diabetes

Diabetes Mellitus, Type 2

Italy
Carmot Therapeutics, Inc.

Recruiting

A Study to Assess the Effects of CT-868 Treatment on Glucose Homeostasis in Participants With Type 1 Diabetes

Type 1 Diabetes

United States
Lundquist Institute for Biomedical Innovation at...
Eli Lilly and Company

Recruiting

Effect of Tirzepatide on Progression of Coronary Atherosclerosis Using MDCT (T-PLAQUE)

Atherosclerosis | Type II Diabetes

United States
Ospedale San Raffaele

Recruiting

Tirzepatide Monotherapy in Patients With Wolfram Syndrome Type 1

Wolfram Syndrome

Italy
AdventHealth Translational Research Institute

Active, not recruiting

Effect of Prolonged (72 Hour) Glucagon Administration on Energy Expenditure in Healthy Obese Subjects (GIO B)

Obesity

United States
Novo Nordisk A/S

Completed

Effect of Liraglutide on Weight and Appetite in Obese Subjects With Type 2 Diabetes

Diabetes Mellitus, Type 2 | Diabetes

Denmark
Novo Nordisk A/S

Completed

Research Study to Investigate How Well Semaglutide Works Compared to Liraglutide in People Living With Overweight or Obesity (STEP 8)

Obesity | Overweight

United States
Uppsala University

Completed

Double-blinded, 6 Months Study With Bydureon® or Placebo in Adolescents With Obesity to Explore Changes in BMI (Combat-JUDO)

Obesity

Sweden, Austria
Eli Lilly and Company

Completed

A Study of Tirzepatide (LY3298176) Compared to Dulaglutide in Participants With Type 2 Diabetes (SURPASS J-mono)

Type 2 Diabetes

Japan
Azienda Ospedaliero-Universitaria di Parma

Active, not recruiting

Long-acting Exenatide and Cognitive Decline in Dysglycemic Patients (DRINN)

Cognitive Deficit | Dysglycemia

Italy
Jens Faber

Completed

LIPT - Liraglutide in Polycystic Ovary Syndrome (LIPT)

Cardiovascular Disease | Polycystic Ovary Syndrome

Denmark
GlaxoSmithKline

Completed

To Investigate the Safety, Tolerability and Pharmacodynamics of GSK2890457 in Healthy Volunteers and Subjects With Type 2 Diabetes

Obesity

United States
Seattle Children's Hospital

Withdrawn

Pharmacology of Exenatide in Pediatric Sepsis (PEPS)

Inflammation | Septic Shock | Glucose Homeostasis | Organ Dysfunction | Health-related Quality of Life

United States
Novo Nordisk A/S

Completed

Efficacy and Safety of Liraglutide Versus Sulphonylurea Both in Combination With Metformin During Ramadan in Subjects With Type 2 Diabetes (LIRA-Ramadan™)

Diabetes Mellitus, Type 2 | Diabetes

India, Israel, Malaysia, South Africa, Algeria, Lebanon, United Arab Emirates
Stanford University

Completed

Liraglutide and a Calorie Restricted Diet Augments Weight Loss and Decreases Risk of Type 2 Diabetes and CVD.

Older Adults | Pre-diabetes
Novo Nordisk A/S

Completed

Safety, Tolerability and Pharmacokinetics of Liraglutide-depot in Healthy Subjects

Healthy | Diabetes Mellitus, Type 2 | Diabetes

United States
Novo Nordisk A/S

Completed

Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 Diabetes

Diabetes Mellitus, Type 2 | Diabetes

Japan
Novo Nordisk A/S

Completed

Safety and Tolerability of Liraglutide in Healthy Male Volunteers

Healthy | Diabetes

United Kingdom

3

Subscribe